"Applications of NMR Spectroscopy is a book series devoted to publishing the latest advances in the applications of nuclear magnetic resonance (NMR) spectroscopy in various fields of organic chemistry, biochemistry, health and agriculture.
 
The ninth volume of the series features reviews that highlight NMR spectroscopic techniques in microbiology, food science, pharmaceutical analysis and cancer diagnosis. The reviews in this volume are:
 
- NMR spectroscopy for the characterization of photoprotective compounds in cyanobacteria
- Coffee assessment using 1H NMR spectroscopy and multivariate data analysis: a review
- Evaluation of structure-property relationship of coconut shell lignins by NMR spectroscopy: from biorefinery to high-added value products
- Application of NMR spectroscopy in chiral recognition of drugs
- NMR-based metabolomics: general aspects and applications in cancer diagnosis"


Applications of NMR Spectroscopy: Volume 9

End User License Agreement (for non-institutional, personal use)

PRINCIPAL PHOTOPROTECTIVE COMPOUNDS IN CYANOBACTERIA

NMR SPECTROSCOPY IN STRUCTURAL ELUCIDATION OF THE UV-PROTECTIVE PIGMENT SCYTONEMIN

NMR Spectroscopy For The Characterization of Photoprotective Compounds in Cyanobacteria

OTHER APPLICATIONS OF METABOLOMICS IN COFFEE

Coffee Assessment Using 1H NMR Spectroscopy and Multivariate Data Analysis: A Review

Structural Elucidation of Lignin by Nuclear Magnetic Resonance (NMR)

Practical Uses of NMR in Lignin Valorization

Evaluation of Structure-property Relationship of Coconut Shell Lignins by NMR Spectroscopy: From Biorefinery to High-added Value Products

Chirality Recognition of Chiral Pharmaceuticals

Application of NMR Spectroscopy in Chiral Recognition of Drugs

SYSTEMS BIOLOGY, METABOLOME AND METABOLOMICS

1H NMR-BASED METABOLOMICS ASSOCIATED WITH CANCER

NMR-Based Metabolomics: General Aspects and Applications in Cancer Diagnosis

Bentham Science Publishers

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eighth volume of the series features chapters covering the following topics:
- T cells in gastrointestinal cancers
- The pharmacology of adjudin – a male contraceptive with anti-cancer properties
- Manipulating the tumor microenvironment
- Treatment of hepatocellular carcinoma
- Gold-based compounds as potential anti-cancer drug candidates
- Oral nanostructure drug delivery for anti-cancer treatment"


Frontiers in Anti-Cancer Drug Discovery: Volume 8

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics:
 
· Essential oils and monoterpenes as potential anti-cancer agents
 
· Drug delivery systems and emerging immunotherapeutic strategies for the treatment of glioblastoma
 
· CTDNA in solid tumors
 
· Cholesterol treatments (including Pitavastatin) and their potential in cancer treatment"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

"Frontiers in CNS Drug Discovery is a book series devoted to publishing reviews which highlight the latest advances in drug design and discovery for disorders of the central nervous system (CNS). Eminent scientists write contributions on all areas of CNS drug design and drug discovery, including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series is essential reading for all pharmaceutical scientists involved in CNS drug design and discovery who wish to keep abreast of rapid and important developments in the field.
 
The third volume of this series brings reviews on brain tumor treatment, neurodegeneration, hyperalgesia, cholinesterase inhibition and much more."


Frontiers in CNS Drug Discovery: Volume 3

"Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The third volume of this series features 6 reviews: 
-Advances in the understanding and treatment of immune thrombocytopenia
-Recent developments in chronic myeloid leukemia biology and treatment
-Role of immunomodulatory drugs in the treatment of lymphoid and myeloid malignancies
-Pediatric hematological malignancies – clinical manifestation, treatment and follow-up
-Novel therapies and immunotherapeutic approaches to treat childhood leukemia
-Erythrocyte turnover and erythropoietic patterns in two different experimental mouse models of anemia"


Frontiers in Clinical Drug Research - Hematology: Volume 3

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents the following reviews:
Asymmetric hydrogenation of tetrasubstituted olefins
Recent advances in catalytic organic synthesis applications of covalently supported ionic liquids
Recent developments in intramolecular cyclization reactions via carbon-heteroatom (c-x) bond formation
Efficient synthetic protocol and mechanistic study of quinazoline analogues and their biological importance
Synthesis of N,O,S-heterocycles by one-pot reactions of epoxides, aziridines and oxaziridines
 "


Advances in Organic Synthesis: Volume 9

"Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The fourth volume of this series features 5 reviews:
-TRP Channels: Potential Therapeutic Targets in Blood Disorders
-Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management
-Advanced Applications of Gene Therapy in the Treatment of Hematologic Disorders
-Ferroptosis - Importance and Potential Effects in Hematological Malignancies
-Clinical Application of Liquid Biopsy in Solid Tumor HCC: Prognostic, Diagnostic and Therapy Monitoring Tool"


Frontiers in Clinical Drug Research - Hematology: Volume 4

Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
 
 
 
The fifth volume of this series features 7 reviews with a focus on thalassemia treatment and preeclampsia among other topics.
 
 
 
- Recent advances in the diagnosis and management of pulmonary embolism
 
- An evidence-based approach to treatment with iron chelators in transfusion- dependent thalassemia patients: present trends and future scenario
 
- Current and future treatments of iron overload in thalassemia patients
 
- Preeclampsia: biological and clinical aspects
 
- Haematological modulations by fixed dose combination (FDC) of tramadol hydrochloride/paracetamol (THP)
 
- Possible use of eculizumab in critically ill patients infected with covid-19 role of complement c5, neutrophils, and nets in the induction DIC, sepsis, and MOF hematological markers
 
- Emerging diagnostic and therapeutic targets in preeclampsia

Frontiers in Clinical Drug Research - Hematology: Volume 5

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
 
 
The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:
 
-Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
 
-Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques
 
-Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions
 
-The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression
 
-Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila
 
-Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

 Zareen Amtul

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The fourth volume of this series features reviews that cover a variety of topics including: 
-Strategies to prolong antibiotic life
-Catalytic antibodies for targeting rabies and influenza viruses
-Antiviral therapies for arenaviruses
-The role of steroids in viral infections
-Monoclonal antibody manufacturing processes
-Prevention and eradication of biofilms in medical devices"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. The series presents comprehensive reviews written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations or optimal product yields. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
Contents of this volume include these 7 reviews:
 
- Recent advances in copper-catalyzed heterocyclic syntheses
- Application of modern green chemistry methods in the synthesis of quinolines, quinazolines and quinazolinones
- Electroluminescence polymers-a review on synthesis by organic compounds
- Multicomponent approach for the synthesis of xanthenes
- From atoms to macromolecules: 100 years of polymer research
- An overview of oxidizing and reducing agents in total synthesis
- Amino acid-derived ionic liquids: novel biodegradable catalytic systems for green synthesis of heterocycles

Sepetiniz

Applications of NMR Spectroscopy: Volume 9

$ 69.00

description_of_book

Ek Bilgi

Yazarlar Hakkında

Atta-ur-Rahman

Frontiers in Anti-Cancer Drug Discovery: Volume 8

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

Frontiers in CNS Drug Discovery: Volume 3

Frontiers in Clinical Drug Research - Hematology: Volume 3

Advances in Organic Synthesis: Volume 9

Frontiers in Clinical Drug Research - Hematology: Volume 4

Frontiers in Clinical Drug Research - Hematology: Volume 5

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

Advances in Organic Synthesis: Volume 16

Atta-ur-Rahman